Author

Naoko Deguchi

Observed name: N Deguchi

Institution: Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital

Observed institutions: Hiroshima University, Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital

OpenAlex ID: A5055004912

Pulmonary cryptococcosis in a ruxolitinib-treated patient with primary myelofibrosis

2017 · Anna Hirano, Masahiro Yamasaki, et al. · Respiratory Medicine Case Reports · 29

[Effectiveness of Nivolumab in Large-Cell Neuroendocrine Carcinoma of the Lung - A Report of Two Cases].

2017 · Wakako Daido, Masahiro Yamasaki, et al. · PubMed · 14

Interferon (Alpha, Beta and Omega) Receptor 2 Is a Prognostic Biomarker for Lung Cancer

2012 · Sonosuke Tanaka, Noboru Hattori, et al. · Pathobiology · 14

Putative lung adenocarcinoma with epidermal growth factor receptor mutation presenting as carcinoma of unknown primary site

2018 · Masahiro Yamasaki, Kunihiko Funaishi, et al. · Medicine · 11

Nivolumab Therapy for Synchronous ALK-Positive Lung Cancer and Gastric Cancer

2017 · Masahiro Yamasaki, Naomi Saito, et al. · Case Reports in Oncology · 9

A Rare Combination of Dermatomyositis, Interstitial Pneumonia, and Lung Cancer in a Patient Treated with Immunosuppressive Therapy and Chemotherapy

2017 · Wakako Daido, Masahiro Yamasaki, et al. · Internal Medicine · 8

[A case of primary mediastinal choriocarcinoma].

2006 · Takashi Yamane, Hiromi Egawa, et al. · PubMed · 7

First-Line Treatment with Carboplatin plus nab-Paclitaxel and Maintenance Monotherapy with nab-Paclitaxel for a Thymic Carcinoma: A Case Report

2017 · Kunihiko Funaishi, Masahiro Yamasaki, et al. · Case Reports in Oncology · 5

Acetylcholine receptor antibody-positive myasthenia gravis associated with small-cell lung cancer

2018 · Masahiro Yamasaki, Kunihiko Funaishi, et al. · Medicine · 4

A bronchial fibroepithelial polyp with abnormal findings on auto-fluorescence imaging

2017 · Naomi Saito, Masahiro Yamasaki, et al. · Respirology Case Reports · 3

Pulmonary Pleomorphic Carcinoma with an EGFR Mutation in a Never-smoker Treated by Nivolumab Therapy Leading to Favorable Disease Control: a Case Report

2017 · Naomi Saito, Wakako Daido, et al. · Haigan · 1

KL-6 is a useful serum biomarker for early detection of interstitial lung disease

2012 · Nobuoki Kohno, Nobuhisa Ishikawa, et al. · European Respiratory Journal · 1

Summer-type hypersensitivity pneumonitis

2018 · M Yamasaki, M Taniwaki, et al. · QJM

Small-cell lung cancer in never smokers: The clinicopathological features including the prognosis

2017 · Masahiro Yamasaki, Naomi Saito, et al. · Cancer Treatment and Research Communications

Front & Back Matter

2012 · Shuichi Hashimoto, Hiroshi Nakano, et al. · Pathobiology

Works count: 15

Citation count: 106

H-index: 7

I10-index: 4